Coherus BioSciences, Inc.
CHRS
$0.7818
-$0.0349-4.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.35% | 72.88% | 69.86% | 235.85% | -35.30% |
| Total Depreciation and Amortization | -2.82% | 72.30% | 34.89% | 58.80% | 1.24% |
| Total Amortization of Deferred Charges | 72.79% | -- | -- | -- | 200.88% |
| Total Other Non-Cash Items | -65.59% | -27.74% | -130.05% | -1,007.95% | 386.96% |
| Change in Net Operating Assets | 756.30% | -122.77% | 1,292.23% | -21.74% | 111.66% |
| Cash from Operations | 321.13% | -14.21% | 253.50% | 31.96% | 87.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.54% | -98.98% | -129.84% | -14.76% | 127.12% |
| Cash from Investing | -101.54% | -99.12% | -33.14% | 1,056.93% | 127.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.95% | -100.00% | -98.85% | -74.08% | -87.42% |
| Repurchase of Common Stock | 96.93% | 94.29% | -460.98% | 73.21% | -165.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 92.38% | 13,489.71% | 52.97% | 45.78% |
| Cash from Financing | -36.89% | -101.50% | -445.93% | -76.68% | -94.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.03% | -939.87% | -277.08% | 430.96% | 110.14% |
